Ana Srnak

Title: Ana Srnak: Innovator in Hemoglobin-Based Solutions

Introduction

Ana Srnak is a prominent inventor based in Skokie, IL (US). She has made significant contributions to the field of biomedical engineering, particularly in the development of hemoglobin-based compositions. With a total of 3 patents to her name, her work has the potential to impact medical treatments and therapies.

Latest Patents

Ana's latest patents include an innovative oxirane-modified hemoglobin-based composition. This non-immunogenic mixture consists of hemoglobin-based modified monomers and oligomers produced through the polymerization of a hemoglobin solution in the presence of a three-membered heterocyclic ring, specifically polyether oxirane. The modified hemoglobin composition boasts a P.sub.50 that is at least equivalent to that of human red blood cell hemoglobin. Additionally, she has developed a process for the production of crosslinked hemoglobin, which involves crosslinking hemoglobin in the presence of sodium tripolyphosphate.

Career Highlights

Ana Srnak is currently employed at Baxter International Inc., where she continues to advance her research and development efforts. Her work at Baxter has positioned her as a key player in the field of hemoglobin-based therapies.

Collaborations

Ana has collaborated with notable colleagues, including Ton That Hai and Deanna J Nelson. These partnerships have further enriched her research and contributed to the success of her innovative projects.

Conclusion

Ana Srnak's contributions to the field of hemoglobin-based solutions demonstrate her commitment to innovation and excellence. Her patents and ongoing work at Baxter International Inc. highlight her role as a leading inventor in biomedical engineering.